文献速递心脑血管急症

血管内成像指导与造影指导的复杂PCI对比

Intravascular Imaging-Guided or Angiography-Guided Complex PCI.
PubMed 文献 · N Engl J Med · 2023-03-05
一句话结论复杂冠脉病变患者中,血管内成像指导PCI较造影指导降低心源性死亡、靶血管相关心梗或临床驱动靶血管血运重建的复合终点风险(HR 0.64)。

这项在韩国开展的前瞻性、多中心、开放标签试验将1639例复杂冠状动脉病变患者按2:1随机分配至血管内成像指导PCI组(1092例)或造影指导PCI组(547例),成像方式(血管内超声或光学相干断层扫描)由术者决定。中位随访2.1年时,血管内成像组主要终点(心源性死亡、靶血管相关心肌梗死或临床驱动靶血管血运重建的复合终点)累积发生率为7.7%,造影组为12.3%(HR 0.64;95%CI 0.45-0.89;P=0.008)。两组操作相关安全性事件发生率无 apparent 差异。

要点

  • 复杂冠脉病变患者随机接受血管内成像指导PCI(1092例)或造影指导PCI(547例),主要终点累积发生率7.7% vs 12.3%(HR 0.64;95%CI 0.45-0.89;P=0.008)。
  • 心源性死亡累积发生率血管内成像组1.7%(16例)vs 造影组3.8%(17例)。
  • 靶血管相关心肌梗死累积发生率血管内成像组3.7%(38例)vs 造影组5.6%(30例)。
  • 临床驱动靶血管血运重建累积发生率血管内成像组3.4%(32例)vs 造影组5.5%(25例)。
  • 两组操作相关安全性事件发生率无 apparent 组间差异。

适用人群与场景

  • 韩国复杂冠状动脉病变患者,接受经皮冠状动脉介入治疗(PCI)。

处置流程与药物剂量

  • 血管内成像指导PCI组:血管内超声或光学相干断层扫描的选择由术者决定。
  • 造影指导PCI组:按造影指导进行PCI。

研究设计与关键结果

  • 研究类型:前瞻性、多中心、开放标签试验,在韩国开展;样本量1639例,随机2:1分配至血管内成像指导PCI组1092例或造影指导PCI组547例。
  • 主要终点:心源性死亡、靶血管相关心肌梗死或临床驱动靶血管血运重建的复合终点;中位随访2.1年(四分位距1.4-3.0),血管内成像组76例(累积发生率7.7%)vs 造影组60例(累积发生率12.3%),HR 0.64(95%CI 0.45-0.89),P=0.008。
  • 心源性死亡:血管内成像组16例(累积发生率1.7%)vs 造影组17例(累积发生率3.8%)。
  • 靶血管相关心肌梗死:血管内成像组38例(累积发生率3.7%)vs 造影组30例(累积发生率5.6%)。
  • 临床驱动靶血管血运重建:血管内成像组32例(累积发生率3.4%)vs 造影组25例(累积发生率5.5%)。
  • 安全性:操作相关安全性事件发生率两组无 apparent 差异。

证据类型、等级与局限

  • 证据类型:前瞻性、多中心、开放标签随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在复杂冠状动脉病变患者中,血管内成像指导PCI较造影指导PCI降低心源性死亡、靶血管相关心肌梗死或临床驱动靶血管血运重建的复合终点风险(HR 0.64;95%CI 0.45-0.89;P=0.008),两组操作相关安全性事件发生率无 apparent 差异。

指南或共识出处

  • RENOVATE-COMPLEX-PCI 试验(ClinicalTrials.gov 注册号 NCT03381872),由 Abbott Vascular 和 Boston Scientific 资助。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Data regarding clinical outcomes after intravascular imaging-guided percutaneous coronary intervention (PCI) for complex coronary-artery lesions, as compared with outcomes after angiography-guided PCI, are limited.

METHODS: In this prospective, multicenter, open-label trial in South Korea, we randomly assigned patients with complex coronary-artery lesions in a 2:1 ratio to undergo either intravascular imaging-guided PCI or angiography-guided PCI. In the intravascular imaging group, the choice between intravascular ultrasonography and optical coherence tomography was at the operators' discretion. The primary end point was a composite of death from cardiac causes, target-vessel-related myocardial infarction, or clinically driven target-vessel revascularization. Safety was also assessed.

RESULTS: A total of 1639 patients underwent randomization, with 1092 assigned to undergo intravascular imaging-guided PCI and 547 assigned to undergo angiography-guided PCI. At a median follow-up of 2.1 years (interquartile range, 1.4 to 3.0), a primary end-point event had occurred in 76 patients (cumulative incidence, 7.7%) in the intravascular imaging group and in 60 patients (cumulative incidence, 12.3%) in the angiography group (hazard ratio, 0.64; 95% confidence interval, 0.45 to 0.89; P = 0.008). Death from cardiac causes occurred in 16 patients (cumulative incidence, 1.7%) in the intravascular imaging group and in 17 patients (cumulative incidence, 3.8%) in the angiography group; target-vessel-related myocardial infarction occurred in 38 (cumulative incidence, 3.7%) and 30 (cumulative incidence, 5.6%), respectively; and clinically driven target-vessel revascularization in 32 (cumulative incidence, 3.4%) and 25 (cumulative incidence, 5.5%), respectively. There were no apparent between-group differences in the incidence of procedure-related safety events.

CONCLUSIONS: Among patients with complex coronary-artery lesions, intravascular imaging-guided PCI led to a lower risk of a composite of death from cardiac causes, target-vessel-related myocardial infarction, or clinically driven target-vessel revascularization than angiography-guided PCI. (Supported by Abbott Vascular and Boston Scientific; RENOVATE-COMPLEX-PCI ClinicalTrials.gov number, NCT03381872).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Lee JM, Choi KH, Song YB, et al. Intravascular Imaging-Guided or Angiography-Guided Complex PCI. N Engl J Med. 2023. PMID: 36876735. doi:10.1056/NEJMoa2216607

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。